Get 20% lifetime commission for referring investors to digrin.com
here.
Oryzon Genomics S.A. (ORYZF) Financials
ORYZF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 160.5 million | 23.9 million |
| March 31, 2026 | 163.0 million | 26.9 million |
| Dec. 31, 2025 | 169.6 million | 31.3 million |
| Sept. 30, 2025 | 171.3 million | 34.1 million |
ORYZF Free Cash Flow and Stock based compensation
No data available :(
ORYZF Net Income
No data available :(
ORYZF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 16.8 million | 1.9 million | - |
| March 31, 2026 | 25.4 million | 3.0 million | 4940 |
| Dec. 31, 2025 | 33.3 million | 7.9 million | 12282 |
| Sept. 30, 2025 | 40.5 million | 4.8 million | 19467 |
ORYZF Shares Outstanding
ORYZF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 4.3 million | -73303 | - |
| March 31, 2026 | - | 5.1 million | 1.5 million | - |
| Dec. 31, 2025 | - | 5.2 million | -2.9 million | - |
| Sept. 30, 2025 | - | 3.9 million | 1.2 million | - |
ORYZF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | 36467 |
| March 31, 2026 | - | 35214 |
| Dec. 31, 2025 | - | 37022 |
| Sept. 30, 2025 | - | 37988 |
ORYZF
Price: $3.10
52 week price:
Earnings Per Share: -0.04 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 253.9 million